Research reveals that reducing anticholinergic burden can significantly enhance cognitive function in patients with psychosis, offering new treatment insights.
Cyrus Abbaszadeh, MD
Advertisement
Dr Abbaszadeh is a first-year psychiatry resident at Creighton University.
Articles by Cyrus Abbaszadeh, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
Progress Report: Second Interim Safety Review of Phase 3 Trial of LPCN 1154 in Postpartum Depression
4
Anticholinergic Burden and Its Effect on Cognition in Psychosis
5